+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06623461

Randomized Trial Evaluating LND101 Fecal Microbiota Transplant with Immune Checkpoint Blockade in Advanced Melanoma

Led by Canadian Cancer Trials Group · Updated on 2026-09-15

128

Participants Needed

15

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating whether adding a treatment called LND101 for Fecal Microbiota Transplant FMT to the usual immunotherapy treatment, Immune Checkpoint Blockade ICB, can reduce the chance of melanoma growing or spreading in people with advanced melanoma. The study compares this combination approach to the standard ICB treatment alone to see which is better for managing advanced melanoma. Immunotherapy aims to activate the immune system to fight the cancer, possibly slowing its growth or killing cancer cells. Participants will be divided into two groups one receiving standard ICB treatment alone, and the other receiving a single dose of LND101 capsules taken by mouth after bowel preparation, followed by standard ICB treatment. Approximately 40 capsules containing processed fecal material are given 7 days before starting the ICB drugs. The choice of ICB drugs, which may be single agents or combinations, is made before participants join the study and remains the same throughout. During the study, participants will be monitored regularly to assess how long they live without disease progression and overall survival over four years. Researchers will also measure tumor response rates and track the number and severity of any side effects. Participants will provide blood and stool samples for analysis and tumor tissue if available. The study requires participants to have measurable disease and be able to take capsules. Follow-up will continue through the study duration to collect safety and effectiveness information.

CONDITIONS

Brief Title

LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma

Research Team

J

Janet Dancey

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here